Dow Up 0.51% Nasdaq Up 0.24%

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS
8.52 Up 0.10(1.19%) Nov 21, 4:00PM EST
|After Hours : 8.52 Up 0.00 (0.01%) Nov 21, 4:45PM EST
Prev Close:8.42
Open:8.58
Bid:7.14 x 100
Ask:N/A
1y Target Est:13.57
Beta:1.9
Next Earnings Date:N/A
Day's Range:8.40 - 8.60
52wk Range:6.88 - 18.18
Volume:883,810
Avg Vol (3m):1,233,410
Market Cap:1.06B
P/E (ttm):N/A
EPS (ttm):-0.71
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
HALOUp 1.19%1.06B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18.18
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.62
Quarterly EPS Est (Dec-14) :-0.11
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes human enzymes. Its research focuses on human enzymes that transiently modify tissue under the skin to facilitate the delivery of injected drugs and ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback